Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Monday, October 21, 2013

Medistem Announces Preclinical Data on Type 1 Diabetes and Filing of Intellectual Property

Medistem, Inc. , announced today that it filed patent application #61/885909 covering immune modulatory aspects of ERC-124, the Company's clinical-stage stem cell product.

http://www.drugs.com/news/medistem-announces-preclinical-data-type-1-diabetes-filing-intellectual-property-48320.html?
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Stem Cell Roundup Posts